Global News: Flow Cytometry Industry worth $9.85 billion by 2033
The report "Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033",is projected to reach USD 9.85 billion by 2033 from USD 5.06 billion in 2025, at a CAGR of 8.7% between 2025 and 2033.
Browse 722 market data Tables and 59 Figures spread through 510 Pages and in-depth TOC on "Flow Cytometry Market - Global Forecast to 2033"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html
The global flow cytometry market is driven by various factors, such as technological advancements causing greater sensitivity and accuracy, higher adoption in clinical diagnostics and research, increasing chronic disease prevalence, growing biopharmaceutical R&D, and the need for personalized medicine. Additionally, artificial intelligence and machine learning integration enhance data analysis capabilities, which is likely to provide impetus to the market growth.
The reagents & consumables segment dominated the flow cytometry market in 2024.
Based on offerings, the flow cytometry market is segmented into software, services, reagents & consumables (antibodies, assays & kits, and other reagents & consumables), instruments, and accessories. Reagents & consumables accounted for the largest share of the flow cytometry market in 2024. The large share of the reagents & consumables market segment can be attributed to the development of high-quality reagents by manufacturers and the continuous commercialization of specific reagents for various clinical & research applications.
The cell-based flow cytometry segment is likely to grow at the highest CAGR during the forecast period of 2025–2033.
Based on technology, the flow cytometry segment is divided into cell-based and bead-based flow cytometry. Cell-based flow cytometry accounted for the dominant share and is expected to grow at a faster pace during the forecast period. Leading factors for cell-based flow cytometry include advancements in single-cell analysis and growing applications in immunology and cancer research. Additionally, growing awareness and adoption in clinical diagnostics, along with supportive government policies and funding for advanced healthcare solutions, further accelerate the growth in this market.
The research application segment is anticipated to grow at a significant CAGR during the forecast period.
Based on applications, the flow cytometry market is segmented into research, clinical, and industrial applications. In 2024, the research applications segment dominated the flow cytometry market. Adoption of flow cytometry in emerging fields like immunotherapy and regenerative medicine fosters further market growth in research applications. The growth of the research applications segment is primarily driven by rising research activity. Several programs, workshops, and symposia have been launched recently to increase awareness of flow cytometry applications in cell-based research.
North America accounted for the largest share of the market in 2024.
North America held the largest market share in the flow cytometry market due to the presence of strong regional competitors with advanced manufacturing capabilities and extensive supply-chain networks. Increasing focus on the development of treatment options for target diseases like cancer and immunological diseases is propelling growth in this region.
Key players in the flow cytometry market include Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), and bioMérieux (France), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Flow Cytometry Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
